Cell Separation Technologies Market - Global Forecast 2026-2032

The Cell Separation Technologies Market is projected to reach USD 12.05 Billion in 2026. It is expected to continue growing at a CAGR of 8.66%, reaching USD 19.90 Billion by 2032.

Cell separation technologies are a foundational capability for modern life sciences, enabling researchers, biomanufacturers, clinical laboratories, and cell therapy developers to isolate targeted cell populations from complex biological samples. The field spans centrifugation, density-gradient separation, filtration, microfluidics, fluorescence-activated cell sorting, magnetic-activated cell sorting, and label-free cell separation approaches used across oncology, immunology, regenerative medicine, stem cell research, infectious disease research, and diagnostics.

Demand is being reinforced by the documented expansion of cell and gene therapy pipelines, the routine use of flow cytometry in translational research, and the growth of single-cell analysis workflows. As laboratories prioritize cell viability, purity, throughput, sterility, and reproducibility, buyers are shifting from manual, operator-dependent methods toward automated and closed-system cell separation platforms that support Good Manufacturing Practice environments and clinical-grade cell processing.

Transformative Shifts in the Cell Separation Landscape

The cell separation landscape is moving from stand-alone instruments toward integrated sample-to-answer ecosystems. Clinical and bioprocessing users increasingly require systems that combine enrichment, washing, concentration, activation, and documentation while minimizing contamination risk. This shift is especially visible in cell therapy manufacturing, where closed and automated cell processing can reduce open handling steps and improve batch-to-batch consistency.

Another transformative change is the rise of high-dimensional biology. Single-cell RNA sequencing, mass cytometry, spatial biology, and multi-omics platforms depend on reliable cell isolation and preparation. As a result, technology selection is no longer based only on recovery rate; it now includes downstream compatibility, cell stress reduction, chain-of-identity controls, digital traceability, assay reproducibility, and regulatory readiness.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is changing how cell separation technologies are designed, operated, and validated. AI-enabled image analysis supports cell identification in imaging flow cytometry and microfluidic systems, while machine learning models can optimize gating strategies, assist rare-cell detection, predict cell viability, and reduce variability in complex immunophenotyping workflows. These applications align with the broader adoption of AI in laboratory automation, quality control, and biomanufacturing informatics.

The cumulative impact of AI is strongest when it is connected to verified data governance, instrument telemetry, and quality-by-design principles. In regulated environments, AI tools must support explainability, auditability, and validation rather than replace scientific oversight. Organizations that combine AI with standardized protocols, secure data architecture, and human-in-the-loop review are better positioned to improve throughput without compromising compliance, sample integrity, or clinical confidence.

Key Regional Insights

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and ASEAN countries invest in biotechnology, oncology research, advanced therapy infrastructure, and domestic biomanufacturing capability. China has become a major center for clinical research in cell therapies, Japan benefits from an established regenerative medicine framework and strong academic-industry collaboration, South Korea is advancing precision oncology and stem cell research, India is strengthening vaccine, biosimilar, and translational medicine capacity, and Australia supports early-phase clinical research and cell therapy development through specialized hospital and academic networks.

North America remains a leading region for cell separation technologies because of the concentration of biopharmaceutical manufacturers, academic medical centers, contract development and manufacturing organizations, and FDA-regulated cell therapy activity across the United States and Canada. The region also benefits from extensive use of flow cytometry, single-cell analysis, immuno-oncology research, and GMP-compliant cell processing. Latin America, led by Brazil and Mexico, is developing demand through public health research, cancer diagnostics, infectious disease studies, and regional biomanufacturing initiatives, although infrastructure, reimbursement, import dependency, and procurement differences influence adoption rates.

Europe is shaped by strong regulatory oversight, active public research funding, and demand for GMP-compliant cell processing across the European Union, United Kingdom, Germany, France, Italy, and Spain. Harmonized clinical research expectations and advanced therapy medicinal product requirements support adoption of validated, traceable cell isolation workflows. The Middle East is increasing investment in precision medicine, genomics, and hospital-based research, particularly in Gulf health systems. Africa is earlier in adoption but has growing relevance in infectious disease research, immunology, hematology, and capacity-building programs that require robust, scalable, and cost-effective cell separation tools.

Key Group Insights

ASEAN demand is supported by expanding biomedical research hubs in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with Singapore serving as a regional anchor for biomanufacturing, translational medicine, and clinical research infrastructure. Within ASEAN, cell separation adoption is closely linked to cancer research, infectious disease surveillance, immunology studies, vaccine-related workflows, and the gradual modernization of hospital laboratories. GCC countries are investing in tertiary care, genomics, precision medicine, and specialty diagnostics, creating opportunities for automated laboratory platforms that support hospital research, cell processing, and high-quality sample preparation.

The European Union benefits from coordinated regulation, multi-country research frameworks, and a mature base of academic, hospital, and commercial laboratories that require validated cell isolation workflows. EU emphasis on advanced therapy medicinal products, data integrity, and quality systems encourages adoption of closed and traceable cell separation technologies. BRICS economies are strategically important because Brazil, Russia, India, China, and South Africa combine large patient populations with rising biotechnology investment and public health research needs, although local manufacturing capacity, import policies, regulatory pathways, and procurement models differ significantly across members.

G7 countries retain strong purchasing power, established regulatory systems, and high demand for advanced cell separation instruments used in cell therapy, immuno-oncology, hematology, regenerative medicine, and single-cell research. These economies also support the development of digital laboratory infrastructure, validated consumables, and service-intensive platforms. NATO members overlap with many advanced research economies, and defense-linked biomedical preparedness, infectious disease monitoring, trauma research, radiation exposure studies, and emergency response planning can indirectly support demand for reliable cell processing and analytical platforms.

Key Country Insights

The United States leads demand through federally funded biomedical research, FDA-regulated advanced therapies, large biopharma clusters, extensive clinical trial infrastructure, and broad adoption of flow cytometry and single-cell analysis. Canada contributes through cell therapy networks, academic hospitals, regenerative medicine initiatives, and biomanufacturing programs, while Mexico benefits from proximity to North American supply chains, expanding clinical laboratory capacity, and growing biomedical research activity. Brazil is the most prominent Latin American country for cell separation technologies, supported by public research institutions, oncology demand, immunology research, infectious disease programs, and bioprocessing activity.

In Europe, the United Kingdom combines strong life science research with advanced therapy manufacturing initiatives, clinical trial expertise, and translational medicine centers. Germany is a major country for laboratory instrumentation, bioprocessing, industrial automation, and high-quality manufacturing, while France supports immunology, oncology, hematology, and public research. Russia maintains scientific capacity in biomedical research but faces procurement and collaboration constraints linked to geopolitical and supply-chain conditions. Italy and Spain show demand across hospital research, diagnostics, academic laboratories, and oncology-focused clinical research.

China is one of the most influential growth countries due to large-scale biopharma investment, expanding clinical studies, domestic instrument development, and increasing use of advanced cell therapy and immuno-oncology workflows. India is building biotechnology capacity through vaccine, biosimilar, diagnostics, stem cell, and cell therapy research, supported by a large clinical research base and growing laboratory modernization. Japan remains strong in regenerative medicine, quality-focused instrumentation, and clinical-grade cell processing, Australia contributes through clinical research, academic medicine, and translational therapy networks, and South Korea is advancing biomanufacturing, stem cell research, precision oncology, and automated laboratory adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize closed, automated, and scalable cell separation platforms that address both research and GMP manufacturing needs. Product roadmaps should focus on viability preservation, high recovery, low shear stress, sterile fluid paths, software traceability, chain-of-identity support, and compatibility with downstream analytics such as flow cytometry, sequencing, imaging, and functional assays.

Commercial strategies should combine regional regulatory expertise with application-specific support. Differentiation can be achieved through validation packages, operator training, service responsiveness, consumable security, localized technical support, and partnerships with contract manufacturers, academic medical centers, hospital laboratories, and translational research networks. AI investments should be tied to measurable improvements in workflow reproducibility, quality control, rare-cell identification, and decision support.

Research Methodology

This executive summary is based on secondary research from authoritative public sources, including regulatory agencies, biomedical research organizations, peer-reviewed literature, clinical trial registries, standards bodies, public health institutions, and publicly available institutional disclosures. The analysis evaluates technology adoption, end-user requirements, regulatory considerations, regional investment patterns, and scientific workflows relevant to cell separation technologies.

Insights were synthesized using a triangulated approach that compares signals across research activity, cell therapy development, laboratory automation, single-cell analysis, biomanufacturing capacity, and healthcare infrastructure. The methodology emphasizes data-backed interpretation, avoids unsupported market sizing claims, and prioritizes verifiable drivers that influence purchasing behavior, technology selection, workflow validation, and long-term adoption of cell isolation platforms.

Conclusion

Cell separation technologies are evolving from routine sample preparation tools into strategic enablers of cell therapy, single-cell biology, immunology, diagnostics, regenerative medicine, and biomanufacturing. The strongest opportunities are emerging where automation, sterility, digital traceability, cell viability, and downstream analytical compatibility converge.

Organizations that invest in validated workflows, AI-supported quality systems, scalable closed platforms, and regionally tailored commercialization strategies will be best positioned to capture demand. As precision medicine expands worldwide, reliable cell isolation will remain a critical determinant of research quality, manufacturing consistency, assay reproducibility, and clinical innovation.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Separation Technologies Market, by Technology

7.1. Introduction
7.2. Acoustic Separation
7.3. Centrifugation
7.3.1. Batch
7.3.2. Continuous
7.4. Field Flow Fractionation
7.5. Filtration
7.5.1. Cross Flow
7.5.2. Dead End
7.6. Magnetic Activated Cell Sorting
7.6.1. Negative Selection
7.6.2. Positive Selection
7.7. Microfluidics
7.7.1. Deterministic Lateral Displacement
7.7.2. Hydrodynamic Separation

8. Cell Separation Technologies Market, by Product

8.1. Introduction
8.2. Consumables
8.2.1. Filters
8.2.2. Kits
8.2.3. Reagents
8.3. Instruments
8.3.1. Acoustic Separators
8.3.2. Centrifuges
8.3.3. Filtration Systems
8.3.4. Magnetic Separators
8.3.5. Microfluidic Devices
8.4. Software
8.4.1. Analysis Software
8.4.2. Automation Software

9. Cell Separation Technologies Market, by Cell Type

9.1. Introduction
9.2. Blood Cells
9.3. Cancer Cells
9.4. Microorganisms
9.5. Stem Cells

10. Cell Separation Technologies Market, by Separation Mode

10.1. Introduction
10.2. Batch
10.3. Continuous

11. Cell Separation Technologies Market, by Application

11.1. Introduction
11.2. Biopharmaceutical Processing
11.2.1. Downstream Processing
11.2.2. Upstream Processing
11.3. Clinical Diagnostics
11.3.1. Cancer Diagnosis
11.3.2. Infectious Disease Testing
11.4. Research
11.4.1. Cell Biology
11.4.2. Drug Discovery
11.4.3. Genomics
11.5. Therapeutics
11.5.1. Cell Therapy
11.5.2. Gene Therapy

12. Cell Separation Technologies Market, by End User

12.1. Introduction
12.2. Academic Institutes
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Hospitals
12.6. Research Laboratories

13. Cell Separation Technologies Market, by Region

13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East

14. Cell Separation Technologies Market, by Group

14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC

15. Cell Separation Technologies Market, by Country

15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. France
15.8. Canada
15.9. Italy
15.10. Australia
15.11. South Korea
15.12. Brazil
15.13. Mexico
15.14. Russia
15.15. Spain

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025

17. Company Profiles

17.1. 10x Genomics, Inc.
17.2. Akadeum Life Sciences, Inc.
17.3. Becton, Dickinson and Company
17.4. Bio-Rad Laboratories, Inc.
17.5. Bio-Techne Corporation
17.6. Cellares Corporation
17.7. Corning Incorporated
17.8. Danaher Corporation
17.9. Eppendorf SE
17.10. Esco Micro Pte. Ltd.
17.11. GE HealthCare Technologies Inc.
17.12. GenScript Biotech Corporation
17.13. Invent Biotechnologies, Inc.
17.14. LevitasBio, Inc.
17.15. Lonza Group AG
17.16. Merck KGaA
17.17. Miltenyi Biotec B.V. & Co. KG
17.18. PerkinElmer, Inc.
17.19. PluriSelect Life Science UG & Co. KG
17.20. Promega Corporation
17.21. QIAGEN N.V.
17.22. Stemcell Technologies Inc.
17.23. Takara Bio Inc.
17.24. Terumo BCT, Inc.
17.25. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ACOUSTIC SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ACOUSTIC SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ACOUSTIC SEPARATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CENTRIFUGATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CENTRIFUGATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BATCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BATCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BATCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FIELD FLOW FRACTIONATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FIELD FLOW FRACTIONATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FIELD FLOW FRACTIONATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FILTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FILTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FILTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CROSS FLOW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CROSS FLOW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CROSS FLOW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DEAD END MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DEAD END MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DEAD END MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NEGATIVE SELECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NEGATIVE SELECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NEGATIVE SELECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL POSITIVE SELECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POSITIVE SELECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POSITIVE SELECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DETERMINISTIC LATERAL DISPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DETERMINISTIC LATERAL DISPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DETERMINISTIC LATERAL DISPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL HYDRODYNAMIC SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL HYDRODYNAMIC SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL HYDRODYNAMIC SEPARATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FILTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FILTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL FILTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ACOUSTIC SEPARATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ACOUSTIC SEPARATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ACOUSTIC SEPARATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CENTRIFUGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CENTRIFUGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CENTRIFUGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL FILTRATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL MAGNETIC SEPARATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MAGNETIC SEPARATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MAGNETIC SEPARATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL AUTOMATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL AUTOMATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL AUTOMATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BLOOD CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BLOOD CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BLOOD CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CANCER CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CANCER CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CANCER CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MICROORGANISMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MICROORGANISMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MICROORGANISMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL BATCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL BATCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL BATCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL CONTINUOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CONTINUOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CONTINUOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CANCER DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CANCER DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL CANCER DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CELL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL CELL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CELL BIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 183. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 184. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 185. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 186. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 187. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 188. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 189. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 190. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 191. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 192. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 193. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 195. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 196. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 197. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 198. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 215. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 216. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 233. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 234. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 237. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 238. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 239. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 240. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 241. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 242. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 243. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 244. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 245. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 246. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 247. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 249. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 250. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 251. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 252. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 270. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 274. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 275. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 276. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 277. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 278. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 279. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 280. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 281. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 282. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 283. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 284. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 285. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 286. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 287. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 288. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 289. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 292. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 293. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 294. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 295. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 296. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 297. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 298. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 299. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 300. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 301. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 302. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 303. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 304. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 305. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 306. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 307. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 327. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 328. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 329. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 330. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 331. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2017-2032 (USD MILLION)
TABLE 332. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 333. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 334. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 335. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 336. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 337. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2017-2032 (USD MILLION)
TABLE 338. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2017-2032 (USD MILLION)
TABLE 340. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 341. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2017-2032 (USD MILLION)
TABLE 342. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 343. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 345. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 346. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2017-2032 (USD MILLION)
TABLE 347. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2017-2032 (USD MILLION)
TABLE 348. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 349. ASEAN

Companies Mentioned

10x Genomics, Inc.
Akadeum Life Sciences, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Cellares Corporation
Corning Incorporated
Danaher Corporation
Eppendorf SE
Esco Micro Pte. Ltd.
GE HealthCare Technologies Inc.
GenScript Biotech Corporation
Invent Biotechnologies, Inc.
LevitasBio, Inc.
Lonza Group AG
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
PerkinElmer, Inc.
PluriSelect Life Science UG & Co. KG
Promega Corporation
QIAGEN N.V.
Stemcell Technologies Inc.
Takara Bio Inc.
Terumo BCT, Inc.
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	197
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 12.05 Billion
Forecasted Market Value ( USD ) by 2032	$ 19.9 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Cell Separation Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cell Isolation/Cell Separation Market - Global Forecast 2026-2032

Cell Separation Technologies - Global Strategic Business Report

Cell Separation Technologies Market Size, Share, Trends and Forecast by Product, Cell Type, Technology, Application, End User, and Region, 2026-2034

Cell Isolation / Cell Separation - Global Strategic Business Report

Cell Separation Market Outlook 2026-2034: Market Share, and Growth Analysis by Product, Technology, Cell Type, Application